Transactions 18
| X |
Filed |
Traded |
Ticker |
Company |
Insider |
Title |
Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
| D |
2026-02-24 |
2026-02-22 |
IBRX |
ImmunityBio, Inc. |
Sachs David C. |
CFO |
F - Tax |
$8.70 |
-20.7K |
300.1K |
-6% |
-$179.9K |
| D |
2026-02-24 |
2026-02-22 |
IBRX |
ImmunityBio, Inc. |
Sachs David C. |
CFO |
M - OptEx |
$0.00 |
+40.6K |
320.8K |
+15% |
$0 |
| D |
2026-02-12 |
2026-02-10 |
IBRX |
ImmunityBio, Inc. |
Sachs David C. |
CFO |
M - OptEx |
$0.00 |
+82.2K |
322.8K |
+34% |
$0 |
| D |
2026-02-12 |
2026-02-10 |
IBRX |
ImmunityBio, Inc. |
Sachs David C. |
CFO |
F - Tax |
$6.93 |
-42.6K |
280.2K |
-13% |
-$295.5K |
| D |
2026-01-05 |
2025-12-31 |
IBRX |
ImmunityBio, Inc. |
Sachs David C. |
CFO |
F - Tax |
$1.98 |
-15.4K |
240.6K |
-6% |
-$30.6K |
| D |
2026-01-05 |
2025-12-31 |
IBRX |
ImmunityBio, Inc. |
Sachs David C. |
CFO |
M - OptEx |
$0.00 |
+30.4K |
256.0K |
+13% |
$0 |
| D |
2025-02-25 |
2025-02-22 |
IBRX |
ImmunityBio, Inc. |
Sachs David C. |
CFO |
M - OptEx |
$0.00 |
+40.6K |
241.5K |
+20% |
$0 |
| D |
2025-02-25 |
2025-02-22 |
IBRX |
ImmunityBio, Inc. |
Sachs David C. |
CFO |
F - Tax |
$3.42 |
-15.9K |
225.6K |
-7% |
-$54.2K |
| D |
2025-01-03 |
2024-12-31 |
IBRX |
ImmunityBio, Inc. |
Sachs David C. |
CFO |
M - OptEx |
$0.00 |
+30.4K |
216.2K |
+16% |
$0 |
| D |
2025-01-03 |
2024-12-31 |
IBRX |
ImmunityBio, Inc. |
Sachs David C. |
CFO |
F - Tax |
$2.56 |
-15.4K |
200.8K |
-7% |
-$39.4K |
| D |
2024-02-02 |
2024-01-31 |
IBRX |
ImmunityBio, Inc. |
Sachs David C. |
CFO |
F - Tax |
$3.36 |
-26.8K |
185.8K |
-13% |
-$90.2K |
| D |
2024-02-02 |
2024-01-31 |
IBRX |
ImmunityBio, Inc. |
Sachs David C. |
CFO |
M - OptEx |
$0.00 |
+70.7K |
212.7K |
+50% |
$0 |
| D |
2024-01-03 |
2023-12-31 |
IBRX |
ImmunityBio, Inc. |
Sachs David C. |
CFO |
F - Tax |
$5.02 |
-10.5K |
141.9K |
-7% |
-$52.8K |
| D |
2024-01-03 |
2023-12-31 |
IBRX |
ImmunityBio, Inc. |
Sachs David C. |
CFO |
M - OptEx |
$0.00 |
+30.4K |
152.4K |
+25% |
$0 |
| D |
2023-09-06 |
2023-09-01 |
IBRX |
ImmunityBio, Inc. |
Sachs David C. |
CFO |
M - OptEx |
$0.00 |
+70.7K |
122.0K |
+138% |
$0 |
| D |
2023-01-04 |
2022-12-31 |
IBRX |
ImmunityBio, Inc. |
Sachs David C. |
CFO |
M - OptEx |
$0.00 |
+7,598 |
51.3K |
+17% |
$0 |
| D |
2021-12-13 |
2021-12-09 |
IBRX |
ImmunityBio, Inc. |
Sachs David C. |
CFO |
M - OptEx |
$0.00 |
+17.2K |
43.7K |
+65% |
$0 |
| D |
2021-09-13 |
2021-09-09 |
IBRX |
ImmunityBio, Inc. |
Sachs David C. |
CFO |
M - OptEx |
$0.00 |
+7,598 |
26.5K |
+40% |
$0 |
Purchase
Sale
Sale after option exercise
All abbreviations